Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
eczema
Pharma
Incyte expects Opzelura to cross $1B in 2026
The topical eczema and vitiligo treatment is enjoying a boost stemming from a recent Medicaid rebate settlement.
Angus Liu
Jul 29, 2026 10:30am
Galderma doubles Nemluvio peak sales outlook to $4B-plus
Mar 5, 2026 11:20am
Leo roars onto Netflix with DTC campaign for new eczema cream
Mar 5, 2026 10:45am
Arcutis adds '90210' star power to skin condition awareness push
Nov 4, 2025 11:00am
Galderma plans to spend $650M on US-based manufacturing
Oct 23, 2025 11:18am
Lilly-backed 'Project Runway' segment ups eczema representation
Oct 9, 2025 10:44am
